Expression of PDGF, IGF-II, bFGF and TGF-beta 1 in pulmonary adenocarcinoma

被引：17

作者：

Takanami, I

Imamuma, T

Hashizume, T

Kikuchi, K

Yamamoto, Y

Yamamoto, T

Kodaira, S

机构：

[1] TEIKYO UNIV,SCH MED,DEPT SURG 1,TOKYO,JAPAN

[2] TEIKYO UNIV,SCH MED,DEPT PATHOL,TOKYO,JAPAN

[3] NATL SANATORIUM,DEPT SURG,KANAGAWA,JAPAN

来源：

PATHOLOGY RESEARCH AND PRACTICE | 1996年 / 192卷 / 11期

关键词：

platelet-derived growth factor; insulin-like growth factor-II; basic fibroblast growth factor; transforming growth factor-beta; pulmonary adenocarcinoma;

D O I：

10.1016/S0344-0338(96)80028-8

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Effects of the expression of the platelet-derived growth factor (PDGF), insulin-like growth factor-II (IGF-II), basic fibroblast growth factor (bFGF) and transforming growth factor (TGF)-beta 1 were studied individually and in combinations with the clinicopathologic features and prognosis of pulmonary adenocarcinoma using paraffin embedded tissue specimens. Tumor sections from 90 patients with pulmonary adenocarcinoma were stained immunohistochemically for PDGF, IGF-II, bFGF and TGF-beta 1 by the ABC method. The survival rate was worse in patients in whom each of the four growth factors was expressed than in those where growth factors were not expressed. The reduced expression of the four growth factors correlated with less tumor agressiveness and better prognosis of pulmonary adenocarcinoma.

引用

页码：1113 / 1120

页数：8

共 43 条

[21]

MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S

[22] ELEVATED LEVELS OF THE ANGIOGENIC PEPTIDE BASIC FIBROBLAST GROWTH-FACTOR IN URINE OF BLADDER-CANCER PATIENTS [J].